- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-small Cell Lung Cancer (Part E) in France
Total 1091 results
-
University Hospital, BrestGroupe Français de Pneumo-CancérologieRecruitingNon-small-cell Lung CancerFrance
-
Bristol-Myers SquibbActive, not recruiting
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, France, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania
-
Achilles Therapeutics UK LimitedRecruitingAdvanced Non Small Cell Lung CancerUnited States, Spain, Germany, France, United Kingdom
-
Erasca, Inc.CompletedAdvanced Non-squamous Non-small-cell Lung CancerUnited States
-
Assistance Publique Hopitaux De MarseilleCompletedNon Small Cell Lung Cancer (NSCLC) | Malignant Pleural Mesothelioma (MPM)France
-
Rennes University HospitalCompletedAdvanced Non Small Cell Lung CancerFrance
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerBelgium, Spain, United Kingdom, Germany, Italy, Poland, France
-
Puma Biotechnology, Inc.CompletedHER2-mutant Non-Small Cell Lung CancerUnited States, France
-
Centre Georges Francois LeclercCompletedNon-small Cell Lung CancerFrance
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, Italy, France, Germany
-
Bristol-Myers SquibbCompletedNon-Squamous Cell Non-small Cell Lung CancerUnited States, Germany, Hong Kong, Spain, Australia, Mexico, Austria, France, Singapore, Switzerland, Canada, Poland, Argentina, Brazil, Chile, Czechia, Hungary, Italy, Norway, Peru, Romania, Russian Federation
-
AstraZenecaCompletedNon-small Cell Lung Cancer (NSCLC)United Kingdom, United States, Italy, Spain, France, Germany
-
Centre René GauducheauCompletedSmall Cell Lung Cancer | CEA-expressing Non Small Cell Lung Carcinoma (NSCLC)France
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Non-Small-Cell Lung AdenocarcinomaUnited States, France, Spain, Netherlands, Czech Republic, Serbia, Romania, Germany, Belgium, Italy, Hungary, United Kingdom, Canada, Poland, Bosnia and Herzegovina, Austria, Slovenia, Croatia, Russian Federation, Ukraine
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, United Kingdom, France, China, Korea, Republic of, Canada, Japan, Netherlands, Italy
-
Intergroupe Francophone de Cancerologie ThoraciqueRecruitingNon Small Cell Lung Cancer | ALK Gene MutationFrance
-
Mirati Therapeutics Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung CancerCanada, United States, Korea, Republic of, Israel, Spain, United Kingdom, Belgium, Germany, Netherlands, Hungary, Italy, Czechia, Australia, Austria, Poland, Argentina, Brazil, Bulgaria, Chile, Colombia, France, Georgia, Greece, Ireland, Malays... and more
-
Xencor, Inc.RecruitingNonsquamous Non-small Cell Lung CancerUnited States
-
AstraZenecaCompletedNon-small Cell Lung CancerItaly, Poland, France, Spain, United States, Russian Federation
-
Sophia Genetics SASRecruitingNon-small Cell Lung Cancer MetastaticUnited States, Spain, France, Israel, Germany, Canada, Italy, Brazil
-
Genentech, Inc.Active, not recruitingNon-small Cell Lung CancerUnited States, Spain, Korea, Republic of, Taiwan, France, Serbia
-
ETOP IBCSG Partners FoundationJanssen PharmaceuticalsRecruitingNon Small Cell Lung CancerSpain, France, Switzerland, United Kingdom, Singapore, Italy, Netherlands
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerSpain, France, United States, United Kingdom, Latvia, Italy, Israel, Argentina, Germany
-
Daiichi SankyoDaiichi Sankyo Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer Metastatic | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorUnited States, Spain, Korea, Republic of, France, United Kingdom, Taiwan, Australia, Japan, China, Netherlands, Italy, Germany, Austria, Belgium, Bulgaria, Singapore
-
Regeneron PharmaceuticalsRegeneron PharmaceuticalsRecruitingNon-small Cell Lung CancerGermany, Austria, France
-
Intergroupe Francophone de Cancerologie ThoraciqueRecruitingNon Small Cell Lung Cancer | BRAF V600EFrance
-
Groupe Français de Pneumo-CancérologieSanofi; Chugai Pharma USACompletedNon Small Cell Lung CancerFrance
-
Centre Paul StraussUnknownColon Cancer | Non-small Cell Lung Cancer Metastatic | Breast Cancer FemaleFrance
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon Small Cell Lung Cancer (Squamous or Non Squamous)France
-
Boehringer IngelheimActive, not recruitingNeoplasms | Non-squamous, Non-Small-Cell Lung CancerUnited States, Spain, Korea, Republic of, France, Hong Kong, United Kingdom, Germany, Australia, Taiwan, Poland, Russian Federation, Ukraine
-
Chugai Pharma FranceFrench College of General Hospital Pneumologists (CPHG); French-Speaking Association... and other collaboratorsCompletedCachexia | Non-small Cell Lung CancerFrance
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerFrance
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
Janssen Research & Development, LLCActive, not recruitingNon-Small-Cell Lung CancerUnited States, France, Taiwan, United Kingdom, China, Spain, Japan, Australia, Korea, Republic of, Canada
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerFrance, Spain, United States, Belgium, Netherlands, Canada, Italy, Singapore, Korea, Republic of, Czechia, Germany, Hong Kong
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerChina, Taiwan, Japan, Korea, Republic of, United States, Australia, Brazil, Canada, France, Germany, Hong Kong, Israel, Italy, Mexico, Spain, Sweden, United Kingdom
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerCanada, Netherlands, Spain, France, Japan, Russian Federation, Germany, Belgium, Greece, Turkey, Taiwan, United States
-
Bristol-Myers SquibbTerminatedNon-small Cell Lung CancerSpain, Belgium, France, Italy, Netherlands, Canada, United Kingdom, United States
-
PfizerRecruitingNSCLC | Non-Small-Cell Lung CancerSpain, China, Taiwan, France, Singapore, Japan, United States
-
AstraZenecaRecruitingNon-small Cell Lung CancerSpain, Italy, France, Canada, Portugal, United States, Czechia, Germany, Sweden, Austria, Hungary
-
MedImmune LLCTerminatedNon-small Cell Lung CancerUnited States, Canada, Japan, Poland, Germany, Hungary, France
-
Rennes University HospitalRecruiting
-
AstraZenecaCompleted
-
University Hospital, Strasbourg, FranceCompleted
-
Central Hospital, Nancy, FranceInstitut de Cancérologie de LorraineEnrolling by invitationLung Cancer | Non Small Cell Lung Cancer | Lung Adenocarcinoma | KRAS Mutation-Related Tumors | EGFR Activating MutationFrance
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)United States, Korea, Republic of
-
Clovis Oncology, Inc.TerminatedNon-small Cell Lung CancerUnited States, Korea, Republic of, Germany, Taiwan, Australia, Hong Kong, Netherlands, Spain, France, United Kingdom, Canada, Switzerland
-
AnHeart Therapeutics Inc.RecruitingNon Small Cell Lung CancerUnited States, Spain, France, Italy, Japan, Korea, Republic of, Canada, China, Poland
-
Summit TherapeuticsAkesoRecruitingNon-Squamous Non-small Cell Lung CancerCanada, United States, Spain, Italy, France, United Kingdom